We have located links that may give you full text access.
Photothermally enhanced bactericidal activity by the combined effect of NIR laser and unmodified graphene oxide against Pseudomonas aeruginosa.
Photodiagnosis and Photodynamic Therapy 2018 August 29
The manuscript shows the application of unmodified graphene oxide (GO) as a photothermally susceptible material to trigger antibacterial effects. The synthesis and characterization of unmodified GO easily dispersed in aqueous solutions is also shown. High GO concentrations in the dark and low GO concentrations irradiated with near infrared light (NIR) produced death in nosocomial bacterium (Pseudomonas aeruginosa). It is demonstrated that GO dispersion in the dark produced a dose-dependent increase in the antibacterial action at concentrations up to 120 µg/mL. On the other hand, by using much lower concentrations (c.a. 2 µg/mL) of GO (non toxic in the dark) and irradiating with near-infrared radiation during 15 min, a degree of mortality of 98.49 % was observed. The P. aeruginosa treated with GO and irradiated exhibited DNA fragmentation due to the physical damage of cell membranes. The GO 2 µg/mL dispersions proved favorable, since they do not induce cell death in the dark, whereas the combination with NIR light triggers the damage to the cell membranes. This characteristic is clearly an advantage in comparison with traditional antibacterial nanomaterials (such as nanoparticles), which induce cell killing due to the nanoparticles toxicity per se. Furthermore, this work provides a novel treatment for combating bacterial nosocomial infections without the use of antibiotics, opening a new area of clinical application via simple photothermal therapy.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app